Skip to content

Assessment of growth and body composition in preterm infants in relation to two different protein intakes: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN99801051
Enrollment
18
Registered
2008-09-05
Start date
2008-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm infant nutrition and body composition Nutritional, Metabolic, Endocrine Preterm infant nutrition

Interventions

To detect a difference of 3.0 g/kg per day in weight gain between the two treatment groups (a = 0.25
power = 80%, assuming SD = 2.0 g/kg per day), 9 patients are required for each group. Preterm infants will be randomised to receive two different schedules of NPT: high or low protein intake for two

Sponsors

Institute of Paediatrics and Neonatology (Italy)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Birth weight between 1000 and 1500 g 2. Being male 3. Being adequate for gestational age (birth weight greater than or equal to 10th percentile according to the Babson and Benda's chart updated) 4. Need for oxygen (O2) less than 40% within the first 72 hours

Exclusion criteria

Exclusion criteria: 1. Starting parenteral nutrition (NPT) after the first 24 hours of life 2. Chromosomal abnormalities 3. Metabolic disease 4. Congenital infections (toxoplasmosis, rubella, cytomegalovirus, herpes simplex and human immunodeficiency virus [HIV] [TORCH]) 5. Score of severity of clinical conditions at birth (CRIBB) greater than 4

Design outcomes

Primary

MeasureTime frame
Safety/tolerance: 1. Haemo-gas analysis twice a week for the first 15 days 2. Blood urea nitrogen and serum ammonium on the 1st day of life, on the 4th/5th, on the 7th/8th and 15th day of life 3. Blood amino acid profile on the 1st day of life (before starting NPT) and on the 4th/5th and 15th day of life

Secondary

MeasureTime frame
Efficacy: 1. Body composition (assessed by means of deuterium and air plethismography-Pea Pod) at birth, at 15 days of life and at 36 weeks of post-conceptional age 2. Growth (weight assessed daily, length and head circumference assessed weekly) 3. Anabolism assessed by means of nitrogen balance on 2nd, 5th, and 8th day of life 4. Blood amino acid profile on the 1st day of life (before starting NPT) and on the 4th/5th and 15th day of life

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026